Currently predicting for Thu, 4 Jun 2026

ABBV Prediction Chart

ABBV Predictions History

Latest community submissions for ABBV.
Predictor Target Session Target Price Result Direction Accuracy Score
Dec 22, 2022 $185.00 +15.21% $162.84 V 86.39% 1
Dom Dom
Dec 22, 2022 Bullish $162.84 V 1
JS JS Pro
Oct 31, 2022 $146.52 -0.74% $146.40 V 99.92% 10
Oct 31, 2022 $149.62 +1.36% $146.40 X 97.80% 0
Oct 31, 2022 $144.29 -2.25% $146.40 V 98.56% 2
Oct 31, 2022 Bullish $146.40 X 0
JS JS Pro
May 16, 2022 $153.72 +0.14% $155.47 V 98.87% 2
May 16, 2022 Bullish $155.47 V 1
Jan 18, 2022 Bullish $136.78 X 1
JS JS Pro
Jan 18, 2022 $136.44 -0.25% $136.78 X 99.75% 6
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ABBV with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT ABBVIE INC
AbbVie
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia ...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE